Literature DB >> 9600862

Monoclonal antibodies to the epitope alpha-Gal-(1-4)-beta-Gal-(1- of Moraxella catarrhalis LPS react with a similar epitope in type IV pili of Neisseria meningitidis.

M Rahman1, A B Jonsson, T Holme.   

Abstract

Murine monoclonal antibodies (MAbs) against the A, B and C LPS serotypes of M. catarrhalis were generated and their binding specificity was examined in an enzyme-linked immunosorbent assay (ELISA). Two broadly cross-reactive monoclonal antibodies (MCA1 and MCC2) against the outer core region of LPS were further characterized. A panel of synthetic glycoproteins and glycolipids was used to determine the binding specificity of the MAbs. MCA1 and MCC2 bound specifically to alpha-Gal-(1-4)-beta-Gal of galabiose and globotriose glycoconjugates. The reactivity of the MAbs with galabiose was higher than that with globotriose. The MAbs could recognize the alpha-Gal-(1-4)-beta-Gal epitope only when it was in a terminal position. MCA1 was further shown to react with a similar epitope in the glycosylated type IV pili of N. meningitidis, which has been shown to contain a 1-4 linked digalactose at the terminal part of the saccharide present in the pili. MCA1 could efficiently recognize this epitope indicating that it was exposed on the surface of the pili. Copyright 1998 Academic Press Limited.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9600862     DOI: 10.1006/mpat.1997.0191

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  9 in total

1.  Multiplex PCR assay that identifies the major lipooligosaccharide serotype expressed by Moraxella catarrhalis clinical isolates.

Authors:  Katie J Edwards; Johanna M Schwingel; Anup K Datta; Anthony A Campagnari
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

2.  Bactericidal monoclonal antibody against Moraxella catarrhalis lipooligosaccharide cross-reacts with Haemophilus Spp.

Authors:  Raina T Gergova; Ianko D Iankov; Iana H Haralambieva; Ivan G Mitov
Journal:  Curr Microbiol       Date:  2007-01-05       Impact factor: 2.188

3.  Characterization of a cluster of three glycosyltransferase enzymes essential for Moraxella catarrhalis lipooligosaccharide assembly.

Authors:  Katie J Edwards; Simon Allen; Bradford W Gibson; Anthony A Campagnari
Journal:  J Bacteriol       Date:  2005-05       Impact factor: 3.490

4.  Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis.

Authors:  Shengqing Yu; Xin-Xing Gu
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

5.  Biochemical analysis of Lpt3, a protein responsible for phosphoethanolamine addition to lipooligosaccharide of pathogenic Neisseria.

Authors:  Ellen T O'Connor; Andrzej Piekarowicz; Karen V Swanson; J McLeod Griffiss; Daniel C Stein
Journal:  J Bacteriol       Date:  2006-02       Impact factor: 3.490

6.  Investigating the potential of conserved inner core oligosaccharide regions of Moraxella catarrhalis lipopolysaccharide as vaccine antigens: accessibility and functional activity of monoclonal antibodies and glycoconjugate derived sera.

Authors:  Andrew D Cox; Frank St Michael; Chantelle M Cairns; Suzanne Lacelle; Amy Lea Filion; Dhamodharan Neelamegan; Cory Q Wenzel; Heather Horan; James C Richards
Journal:  Glycoconj J       Date:  2011-05-18       Impact factor: 2.916

7.  Functional characteristics of a protective monoclonal antibody against serotype A and C lipooligosaccharides from Moraxella catarrhalis.

Authors:  W G Hu; J Chen; J C McMichael; X X Gu
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

8.  Galactose residues on the lipooligosaccharide of Moraxella catarrhalis 26404 form the epitope recognized by the bactericidal antiserum from conjugate vaccination.

Authors:  Shengqing Yu; Hang Xie; Anup Datta; Natasha Naidu; Xin-Xing Gu
Journal:  Infect Immun       Date:  2008-06-16       Impact factor: 3.441

9.  Intranasal immunization of the combined lipooligosaccharide conjugates protects mice from the challenges with three serotypes of Moraxella catarrhalis.

Authors:  Dabin Ren; Hang Xie; Wenhong Zhang; Ferdaus Hassan; Ronald S Petralia; Shengqing Yu; David J Lim; Xin-Xing Gu
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.